𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies

✍ Scribed by Howard, Campbell; Noe, Adele; Skerjanec, Andrej; Holzhauer, Björn; Wernsing, Margaret; Ligueros-Saylan, Monica; Thuren, Tom


Book ID
125400406
Publisher
BioMed Central
Year
2014
Tongue
English
Weight
326 KB
Volume
13
Category
Article
ISSN
1475-2840

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES